Speaker illustration

Doctor Soojin Kim

Busan ()

Prasugrel or clopidogrel in non-st-elevation acute coronary syndrome with CYP2C19 genetic variants undergoing percutaneous coronary intervention

Event: ESC Congress 2018

Topic: Antiplatelet Drugs

Session: Pharmacogenetics - New sights on the horizon

Thumbnail

Comparison of influencing factors on platelet reactivity in various platelet function test after percutaneous coronary interventions

Event: ESC CONGRESS 2017

Topic: Ischaemia, experimental studies

Session: Coronary artery disease: from bench to bedside

Thumbnail

This platform is supported by

logo Novo Nordisk